Venus Concept Inc. Forms 3, 4 and 5: Warrants
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 29 rows, 29 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-12-18: Reporting owner Madryn Health Partners (Cayman Master), LP | Madryn Health Advisors, LP | Madryn Health Partners, LP | Madryn Asset Management, LP; Form 3; Security Warrants; Transaction Holding.
- 2020-12-18: Reporting owner Madryn Health Partners (Cayman Master), LP | Madryn Health Advisors, LP | Madryn Health Partners, LP | Madryn Asset Management, LP; Form 3; Security Warrants; Transaction Holding.
- 2020-03-19: Reporting owner Saudi Economic & Development Securities Co | SEDCO Capital Global Funds - SC Private Equity Global Fund IV; Form 3; Security Warrant; Transaction Holding.
- 2020-03-18: Reporting owner HealthQuest Venture Management II, L.L.C. | HealthQuest Partners II, L.P.; Form 4; Security Warrant (right to buy); Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-12-18 holding as of filing | Madryn Health Partners (Cayman Master), LP | Madryn Health Advisors, LP | Madryn Health Partners, LP | Madryn Asset Management, LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrants Derivative · Indirect · See footnotes | Holding | $8.78 exercise price | 2020-12-18 | ||
| 2020-12-18 holding as of filing | Madryn Health Partners (Cayman Master), LP | Madryn Health Advisors, LP | Madryn Health Partners, LP | Madryn Asset Management, LP 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrants Derivative · Indirect · See footnotes | Holding | $8.78 exercise price | 2020-12-18 | ||
| 2020-03-19 holding as of filing | Saudi Economic & Development Securities Co | SEDCO Capital Global Funds - SC Private Equity Global Fund IV 10% Owner | 10% Owner | 3 | Warrant Derivative · Indirect · See footnotes | Holding | $3.50 exercise price | 2020-03-19 | ||
| 2020-03-18 | HealthQuest Venture Management II, L.L.C. | HealthQuest Partners II, L.P. 10% Owner | 10% Owner | 4 | Warrant (right to buy) Derivative · Direct | P Open market or private purchase of non-derivative or derivative security | +900,000 900,000 owned after | $3.50 exercise price | 2020-03-20 | |
| 2020-03-18 | Kong Garheng Director, 10% Owner | 4 | Warrant (right to buy) Derivative · Indirect · By Partnership | P Open market or private purchase of non-derivative or derivative security | +900,000 900,000 owned after | $3.50 exercise price | 2020-03-20 | |
| 2020-03-18 | BARRY RICHARD SCOTT Director, 10% Owner | 4 | Warrant (right to buy) Derivative · Indirect · By Partnership | P Open market or private purchase of non-derivative or derivative security | +3,893,360 3,893,360 owned after | $3.50 exercise price | 2020-03-20 | |
| 2020-03-18 | BARRY RICHARD SCOTT Director, 10% Owner | 4 | Warrant (right to buy) Derivative · Indirect · By Partnership | P Open market or private purchase of non-derivative or derivative security | +156,640 156,640 owned after | $3.50 exercise price | 2020-03-20 | |
| 2020-03-18 | EW Healthcare Partners-A, L.P. | Essex Woodlands IX, LLC | EW Healthcare Partners, L.P. | Essex Woodlands Fund IX-GP, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrant (rights to buy) Derivative · Direct · (m) | P Open market or private purchase of non-derivative or derivative security | +3,893,360 3,893,360 owned after | $3.50 exercise price | 2020-03-20 | |
| 2020-03-18 | EW Healthcare Partners-A, L.P. | Essex Woodlands IX, LLC | EW Healthcare Partners, L.P. | Essex Woodlands Fund IX-GP, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrant (rights to buy) Derivative · Indirect · (m) | P Open market or private purchase of non-derivative or derivative security | +156,640 156,640 owned after | $3.50 exercise price | 2020-03-20 | |
| 2020-03-18 | SEDCO Capital Cayman Ltd | Saudi Economic & Development Securities Co 10% Owner | 10% Owner | 4 | Warrant Derivative · Indirect · See footnotes | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +660,000 495,000 owned after | $3.50 exercise price | 2020-03-19 | |
| 2020-03-18 | SEDCO Capital Cayman Ltd | Saudi Economic & Development Securities Co 10% Owner | 10% Owner | 4 | Warrant Derivative · Indirect · See footnotes | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,600,000 1,200,000 owned after | $3.50 exercise price | 2020-03-19 | |
| 2019-11-15 holding as of filing | SC Venus Opportunities Ltd | SEDCO Capital Cayman Ltd | SC Venus US Ltd | Saudi Economic & Development Securities Co 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrant Derivative · Indirect · See footnotes | Holding | $6.00 exercise price | 2019-11-15 | ||
| 2019-11-15 holding as of filing | SC Venus Opportunities Ltd | SEDCO Capital Cayman Ltd | SC Venus US Ltd | Saudi Economic & Development Securities Co 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrant Derivative · Indirect · See footnotes | Holding | $6.00 exercise price | 2019-11-15 | ||
| 2019-11-15 holding as of filing | SC Venus Opportunities Ltd | SEDCO Capital Cayman Ltd | SC Venus US Ltd | Saudi Economic & Development Securities Co 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Warrant Derivative · Indirect · See footnotes | Holding | $6.00 exercise price | 2019-11-15 | ||
| 2019-11-07 | Essex Woodlands IX, LLC | EW Healthcare Partners, L.P. | EW Healthcare Partners-A, L.P. | Essex Woodlands Fund IX-GP, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrant (right to buy) Derivative · Direct · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,439,437 1,439,437 owned after | $6.00 exercise price | 2019-11-08 | |
| 2019-11-07 | Essex Woodlands IX, LLC | EW Healthcare Partners, L.P. | EW Healthcare Partners-A, L.P. | Essex Woodlands Fund IX-GP, L.P. 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Warrant (right to buy) Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,911 57,911 owned after | $6.00 exercise price | 2019-11-08 | |
| 2019-11-07 | BARRY RICHARD SCOTT Director, 10% Owner | 4 | Warrants (right to buy) Derivative · Indirect · By Partnership | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,439,437 1,439,437 owned after | $6.00 exercise price | 2019-11-08 | |
| 2019-11-07 | BARRY RICHARD SCOTT Director, 10% Owner | 4 | Warrants (right to buy) Derivative · Indirect · By Partnership | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +57,911 57,911 owned after | $6.00 exercise price | 2019-11-08 | |
| 2019-11-07 | HealthQuest Partners II, L.P. | HealthQuest Venture Management II, L.L.C. 10% Owner | 10% Owner | 4 | Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,333,333 1,333,333 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Kong Garheng Director, 10% Owner | 4 | Warrants (right to buy) Derivative · Indirect · By Partnership | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,333,333 1,333,333 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Natale Anthony Director | 4 | Warrants (right to buy) Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,896 20,896 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Natale Anthony Director | 4 | Warrants (right to buy) Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,001 2,001 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Natale Anthony Director | 4 | Warrants (right to buy) Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,769 3,769 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Natale Anthony Director | 4 | Warrants (right to buy) Derivative · Indirect · (m) | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,666 26,666 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Kelley William Bernard Officer (President, Global Sales) | 4 | Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,333 13,333 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Sinay Soren Maor Officer (Chief Operating Officer) | 4 | Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +66,659 66,659 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Kang Melissa Officer (VP, Global Marketing) | 4 | Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,333 9,333 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Della Penna Domenic Officer (Chief Financial Officer) | 4 | Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +26,663 26,663 owned after | $6.00 exercise price | 2019-11-07 | |
| 2019-11-07 | Vaynberg Boris Officer (Chief Technology Officer) | 4 | Warrants (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,333 5,333 owned after | $6.00 exercise price | 2019-11-07 |